Literature DB >> 22655479

Imaging of spondylodiscitis.

A Leone1, C Dell'Atti, N Magarelli, P Colelli, A Balanika, R Casale, L Bonomo.   

Abstract

BACKGROUND: Spinal infections (pyogenic or non-pyogenic) are increasing in incidence and are a common cause of morbidity in high-risk patients (elderly, immunocompromised patients, diabetic patients, drug addicts, and patients with sickle-cell disease). AIM: To provide an overview of the radiological features of spinal infections, focusing on magnetic resonance (MR) imaging, and to illustrate the differential diagnosis.
MATERIALS AND METHODS: We reviewed the spine imaging of 118 patients with spinal infections from our files. All patients underwent radiography and MR imaging examinations. computed tomography (CT) was performed in 96 patients.
RESULTS: MR imaging has greatly contributed to prompt diagnosis, thus allowing implementation of timely appropriate treatment.
CONCLUSIONS: Prompt diagnosis and treatment are essential to prevent serious bone and joint destruction, and severe neurologic sequelae.

Entities:  

Mesh:

Year:  2012        PMID: 22655479

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  14 in total

1.  Spontaneous Spinal Discitis and Spondylodiscitis: Clinicotherapeutic Remarks.

Authors:  Alessandro Landi; Giovanni Grasso; Giancarlo Iaiani; Fabrizio Gregori; Cristina Mancarella; Alessandro di Bartolomeo; Maurizio Domenicucci; Roberto Delfini
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec

2.  Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients.

Authors:  Enrico Pola; F Taccari; G Autore; F Giovannenze; V Pambianco; R Cauda; G Maccauro; M Fantoni
Journal:  Eur Spine J       Date:  2018-04-17       Impact factor: 3.134

3.  Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults.

Authors:  Elena Lazzeri; Alessandro Bozzao; Maria Adriana Cataldo; Nicola Petrosillo; Luigi Manfrè; Andrej Trampuz; Alberto Signore; Mario Muto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-09       Impact factor: 9.236

4.  New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years.

Authors:  Enrico Pola; G Autore; V M Formica; V Pambianco; D Colangelo; R Cauda; M Fantoni
Journal:  Eur Spine J       Date:  2017-03-21       Impact factor: 3.134

Review 5.  Spinal infection: state of the art and management algorithm.

Authors:  Rui M Duarte; Alexander R Vaccaro
Journal:  Eur Spine J       Date:  2013-06-12       Impact factor: 3.134

6.  A case of epidemic myalgia with symptoms resembling acute purulent spondylitis and discitis.

Authors:  Tsuneaki Kenzaka; Yukariko Hida; Masanori Matsumoto; Hozuka Akita
Journal:  BMC Musculoskelet Disord       Date:  2016-08-04       Impact factor: 2.362

Review 7.  Magnetic Resonance Imaging Findings of Early Spondylodiscitis: Interpretive Challenges and Atypical Findings.

Authors:  Jeong A Yeom; In Sook Lee; Hie Bum Suh; You Seon Song; Jong Woon Song
Journal:  Korean J Radiol       Date:  2016-08-23       Impact factor: 3.500

8.  Radiologic Diagnosis of Spondylodiscitis, Role of Magnetic Resonance.

Authors:  Naser Ramadani; Kreshnike Dedushi; Serbeze Kabashi; Sefedin Mucaj
Journal:  Acta Inform Med       Date:  2017-03

Review 9.  Management of spinal infection: a review of the literature.

Authors:  Sara Lener; Sebastian Hartmann; Giuseppe M V Barbagallo; Francesco Certo; Claudius Thomé; Anja Tschugg
Journal:  Acta Neurochir (Wien)       Date:  2018-01-22       Impact factor: 2.216

10.  Primary acquired spondylodiscitis shows a more severe course than spondylodiscitis following spine surgery: a single-center retrospective study of 159 cases.

Authors:  Anja Tschugg; Sara Lener; Sebastian Hartmann; Andreas Rietzler; Sabrina Neururer; Claudius Thomé
Journal:  Neurosurg Rev       Date:  2017-02-27       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.